Oxford Biomedica

Oxford Biomedica is a gene and cell therapy company specialising in the development of gene-based medicines. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.[2

Wikipedia

lensPlanning

Oxford Biomedica doesn’t publicly share any plans to support the goals

lensCommitments

Oxford Biomedica doesn’t publicly declare any measurable commitments to support the goals

lensActions

Oxford Biomedica publicly shares examples of positive environmental / social actions, but doesn’t say how these support the goals

lensProgress

Oxford Biomedica publicly shares environmental / social data, but doesn’t how this supports progress towards the goals

lensSuppliers

Oxford Biomedica shares information about involving its suppliers in environmental / social issues but doesn’t mention involving them in supporting the goals

Review date: 25 October 2020
Country: United Kingdom